Avandia/Insulin Safety Warnings Cited In FDA Ad Letters To GSK

GlaxoSmithKline and FDA will discuss an Avandia "Dear Doctor" letter to highlight new safety labeling related to use with insulin following a warning letter issued to the company July 17.